Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.
Mega JL, Simon T, Collet JP, Anderson JL, Antman EM, Bliden K, Cannon CP, Danchin N, Giusti B, Gurbel P, Horne BD, Hulot JS, Kastrati A, Montalescot G, Neumann FJ, Shen L, Sibbing D, Steg PG, Trenk D, Wiviott SD, Sabatine MS.
Mega JL, et al. Among authors: simon t.
JAMA. 2010 Oct 27;304(16):1821-30. doi: 10.1001/jama.2010.1543.
JAMA. 2010.
PMID: 20978260
Free PMC article.